Cartalax
Cartalax (Ala-Glu-Asp) is a synthetic tripeptide bioregulator investigated in preclinical research for its role in cartilage homeostasis and extracellular matrix regulation.
Tap I use this — we'll set up your dose, reminders & journey in 30 seconds.
Cartalax (Ala-Glu-Asp, also designated T-31 or AED) is a synthetic tripeptide bioregulator investigated in preclinical laboratory research for its role in cartilage homeostasis, extracellular matrix (ECM) regulation, and connective-tissue biology. The sequence is derived from a regulatory region of the alpha-1 chain of type XI collagen, a structural component critical to cartilage matrix organization. As a short, tissue-associated peptide, Cartalax is used as a research tool to explore transcriptional regulation, ECM marker readouts, and matrix turnover pathways in chondrocyte and connective-tissue models under controlled experimental conditions.
- Peptide
- Cartalax
- Strength
- 20 mg
- Package
- 20 mg
- Purity
- 99%
- Form
- vial
